89 related articles for article (PubMed ID: 24021352)
21. Cytotoxic and antibacterial sesquiterpenes from Thespesia populnea.
Boonsri S; Karalai C; Ponglimanont C; Chantrapromma S; Kanjana-Opas A
J Nat Prod; 2008 Jul; 71(7):1173-7. PubMed ID: 18553924
[TBL] [Abstract][Full Text] [Related]
22. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of C-ring aromatized analogues of phenanthridone alkaloids.
Lee S; Hwang S; Yu S; Jang W; Lee YM; Kim S
Arch Pharm Res; 2011 Jul; 34(7):1065-70. PubMed ID: 21811912
[TBL] [Abstract][Full Text] [Related]
24. [Effect of Janus kinase inhibitor AG490 on invasion and metastasis of human breast cancer cells].
Chen HF; Deng HY; Fan WK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):63-5, 83. PubMed ID: 18390202
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer.
Jung M; Lee S; Ham J; Lee K; Kim H; Kim SK
J Med Chem; 2003 Mar; 46(6):987-94. PubMed ID: 12620075
[TBL] [Abstract][Full Text] [Related]
26. Generation of 'Unnatural Natural Product' library and identification of a small molecule inhibitor of XIAP.
Kawamura T; Matsubara K; Otaka H; Tashiro E; Shindo K; Yanagita RC; Irie K; Imoto M
Bioorg Med Chem; 2011 Jul; 19(14):4377-85. PubMed ID: 21696964
[TBL] [Abstract][Full Text] [Related]
27. Development of selective, potent RabGGTase inhibitors.
Stigter EA; Guo Z; Bon RS; Wu YW; Choidas A; Wolf A; Menninger S; Waldmann H; Blankenfeldt W; Goody RS
J Med Chem; 2012 Oct; 55(19):8330-40. PubMed ID: 22963166
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and in vitro anticancer activity of 6,7-methylenedioxy (or 5-hydroxy-6-methoxy)-2-(substituted selenophenyl)quinolin-4-one analogs.
Chen CT; Hsu MH; Cheng YY; Liu CY; Chou LC; Huang LJ; Wu TS; Yang X; Lee KH; Kuo SC
Eur J Med Chem; 2011 Dec; 46(12):6046-56. PubMed ID: 22030314
[TBL] [Abstract][Full Text] [Related]
29. Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary amines.
Dasari R; De Carvalho A; Medellin DC; Middleton KN; Hague F; Volmar MN; Frolova LV; Rossato MF; De La Chapa JJ; Dybdal-Hargreaves NF; Pillai A; Kälin RE; Mathieu V; Rogelj S; Gonzales CB; Calixto JB; Evidente A; Gautier M; Munirathinam G; Glass R; Burth P; Pelly SC; van Otterlo WA; Kiss R; Kornienko A
Eur J Med Chem; 2015 Oct; 103():226-37. PubMed ID: 26360047
[TBL] [Abstract][Full Text] [Related]
30. OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells.
Kim MJ; Nam HJ; Kim HP; Han SW; Im SA; Kim TY; Oh DY; Bang YJ
Cancer Lett; 2013 Jul; 335(1):145-52. PubMed ID: 23402820
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and preliminary biological evaluation of novel taspine derivatives as anticancer agents.
Zhang J; Zhang Y; Shan Y; Li N; Ma W; He L
Eur J Med Chem; 2010 Jul; 45(7):2798-805. PubMed ID: 20304537
[TBL] [Abstract][Full Text] [Related]
32. Staurosporine induces megakaryocytic differentiation through the upregulation of JAK/Stat3 signaling pathway.
Peng HY; Liao HF
Ann Hematol; 2011 Sep; 90(9):1017-29. PubMed ID: 21331591
[TBL] [Abstract][Full Text] [Related]
33. Tridemethylisovelleral, a potent cytotoxic agent.
Aujard I; Röme D; Arzel E; Johansson M; de Vos D; Sterner O
Bioorg Med Chem; 2005 Nov; 13(22):6145-50. PubMed ID: 16055337
[TBL] [Abstract][Full Text] [Related]
34. Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1).
Neelakantan S; Nasim S; Guzman ML; Jordan CT; Crooks PA
Bioorg Med Chem Lett; 2009 Aug; 19(15):4346-9. PubMed ID: 19505822
[TBL] [Abstract][Full Text] [Related]
35. Antineoplastic agents. 499. Synthesis of hystatin 2 and related 1H-benzo[de][1,6]-naphthyridinium salts from aaptamine.
Pettit GR; Hoffmann H; Herald DL; Blumberg PM; Hamel E; Schmidt JM; Chang Y; Pettit RK; Lewin NE; Pearce LV
J Med Chem; 2004 Mar; 47(7):1775-82. PubMed ID: 15027869
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, structure-activity relationship and biological evaluation of anticancer activity for novel N-substituted sophoridinic acid derivatives.
Li X; Zhao WL; Jiang JD; Ren KH; Du NN; Li YB; Wang YX; Bi CW; Shao RG; Song DQ
Bioorg Med Chem Lett; 2011 Sep; 21(18):5251-4. PubMed ID: 21807514
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design.
Yu W; Xiao H; Lin J; Li C
J Med Chem; 2013 Jun; 56(11):4402-12. PubMed ID: 23651330
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of 5-benzyl-2-phenylpyrazolo[1,5-a]pyrazin-4,6(5H,7H)-dione derivatives and discovery of an apoptosis inducer for H322 lung cancer cells.
Lv HS; Kong XQ; Ming QQ; Jin X; Miao JY; Zhao BX
Bioorg Med Chem Lett; 2012 Jan; 22(2):844-9. PubMed ID: 22209459
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of a 1,4-benzodiazepine containing palladacycle with in vitro anticancer and cathepsin B activity.
Spencer J; Rathnam RP; Motukuri M; Kotha AK; Richardson SC; Hazrati A; Hartley JA; Male L; Hursthouse MB
Dalton Trans; 2009 Jun; (22):4299-303. PubMed ID: 19662306
[TBL] [Abstract][Full Text] [Related]
40. Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity.
Page BD; Khoury H; Laister RC; Fletcher S; Vellozo M; Manzoli A; Yue P; Turkson J; Minden MD; Gunning PT
J Med Chem; 2012 Feb; 55(3):1047-55. PubMed ID: 22148584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
